CD19 and sarcopenia: The multivariate Cox regression analysis showed that pathological tumour–node–metastasis stage, CD19+ cells, sarcopenia and CD3+/CD4+ cell–myosteatosis were identified as independent prognostic factors for PFS and OS in patients.